Depression is a highly prevalent in Parkinson's disease (PD) and is often said to contribute more to the lowered quaUty of life than the debilitating motor symptoms. Although the etiology of depression in PD is unknown, understanding the potential pathophysiological processes and deleterious consequences of these co-morbidities is of high importance, and may lead to the development of novel treatment therapies. Currently, models aimed at deciphering the complex neurobiological interactions of PD and depression are lacking. In the proposed studies, we will combine the intrastriatal 6-hydroxydopamine rat model of PD with a widely accepted rat model of stress-induced depression symptomology (chronic variable stress model), to test the hypothesis that experimental depression exacerbates the neurodegeneration and associated dysfunction of the injured nigrostriatal dopaminergic system via deleterious glucocorticoid mechanisms as evaluated by functional, morphological, neurochemical, and gene expression analyses. To test potential mechanisms by which depression may increase nigrostriatal vulnerability, SPECIFIC AIM #1 will evaluate the necessity and sufficiency of glucocorticoids in dopaminergic degeneration and motor dysfimction, and determine plausible molecular correlates contributing to the enhanced degeneration. In the context of the dopaminergic mesotelencephalic system, these aims will be addressed by using forelimb-use asymmetry behavioral tests, tyrosine hydroxylase immimohistochemistry, unbiased stereology, HPLC analysis of dopamine and its metabolites, and custom PCR arrays. The overall goal of this project is to gain functional, morphological and mechanistic insight into the co-morbidity of PD, stress and depression. Moreover, this research may lead to future therapies that ameliorate alTective as well as motor symptoms of PD.

Public Health Relevance

Almost half of all patients with Parkinson's disease experience coexisting major depression. The present research will investigate whether having abnormal levels of stress hormones is a mechanism by which depression worsens motor symptoms and accelerates nerve cell death in PD. This work will help us understand the underlying mechanisms interacting in these two co-morbid disorders and may reveal novel therapeutic approaches to relieve both mood and motor symptoms of PD.

National Institute of Health (NIH)
National Institute of Neurological Disorders and Stroke (NINDS)
Specialized Center (P50)
Project #
Application #
Study Section
National Institute of Neurological Disorders and Stroke Initial Review Group (NSD)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Michigan State University
East Lansing
United States
Zip Code
Polinski, Nicole K; Gombash, Sara E; Manfredsson, Fredric P et al. (2015) Recombinant adenoassociated virus 2/5-mediated gene transfer is reduced in the aged rat midbrain. Neurobiol Aging 36:1110-20
Gombash, S E; Manfredsson, F P; Mandel, R J et al. (2014) Neuroprotective potential of pleiotrophin overexpression in the striatonigral pathway compared with overexpression in both the striatonigral and nigrostriatal pathways. Gene Ther 21:682-93
Hemmerle, A M; Dickerson, J W; Herman, J P et al. (2014) Stress exacerbates experimental Parkinson's disease. Mol Psychiatry 19:638-40
Levine, Nathan D; Rademacher, David J; Collier, Timothy J et al. (2013) Advances in thin tissue Golgi-Cox impregnation: fast, reliable methods for multi-assay analyses in rodent and non-human primate brain. J Neurosci Methods 213:214-27
Madhavan, Lalitha; Daley, Brian F; Sortwell, Caryl E et al. (2012) Endogenous neural precursors influence grafted neural stem cells and contribute to neuroprotection in the parkinsonian rat. Eur J Neurosci 35:883-95
Hemmerle, Ann M; Herman, James P; Seroogy, Kim B (2012) Stress, depression and Parkinson's disease. Exp Neurol 233:79-86
Gombash, Sara E; Lipton, Jack W; Collier, Timothy J et al. (2012) Striatal pleiotrophin overexpression provides functional and morphological neuroprotection in the 6-hydroxydopamine model. Mol Ther 20:544-54
Spieles-Engemann, Anne L; Steece-Collier, Kathy; Behbehani, Michael M et al. (2011) Subthalamic nucleus stimulation increases brain derived neurotrophic factor in the nigrostriatal system and primary motor cortex. J Parkinsons Dis 1:123-36
Kordower, Jeffrey H; Dodiya, Hemraj B; Kordower, Adam M et al. (2011) Transfer of host-derived * synuclein to grafted dopaminergic neurons in rat. Neurobiol Dis 43:552-7
Soderstrom, Katherine E; O'Malley, Jennifer A; Levine, Nathan D et al. (2010) Impact of dendritic spine preservation in medium spiny neurons on dopamine graft efficacy and the expression of dyskinesias in parkinsonian rats. Eur J Neurosci 31:478-90

Showing the most recent 10 out of 12 publications